Endometrial BCL6 testing for the prediction of in vitro fertilization outcomes: a cohort study Laura D. Almquist, M.D., Creighton E. Likes, M.D., Benjamin Stone, B.S., Kaitlin R. Brown, B.S., Ricardo Savaris, M.D., Ph.D., David A. Forstein, D.O., Paul B. Miller, M.D., Bruce A. Lessey, M.D., Ph.D. Fertility and Sterility Volume 108, Issue 6, Pages 1063-1069 (December 2017) DOI: 10.1016/j.fertnstert.2017.09.017 Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions
Figure 1 Flow diagram of the study. Fertility and Sterility 2017 108, 1063-1069DOI: (10.1016/j.fertnstert.2017.09.017) Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions
Figure 2 Expression patterns of BCL6. (A) Normal, in phase endometrium; inset: lymph node (positive control). (B) Endometrium from patient with endometriosis who had IVF failure. Bars = 50 μm. (C) Percentage of pregnant women (bars = 95% confidence interval) according to BCL6 expression: normal (≤1.4 HSCORE) or abnormal (overexpressed) of BCL6 (>1.4 HSCORE). Fertility and Sterility 2017 108, 1063-1069DOI: (10.1016/j.fertnstert.2017.09.017) Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions